US6936439B2
(en)
*
|
1995-11-22 |
2005-08-30 |
Amgen Inc. |
OB fusion protein compositions and methods
|
EP1263285A2
(de)
*
|
2000-03-14 |
2002-12-11 |
Alnis Biosciences, Inc. |
Gefrierschutzsystem
|
US7018645B1
(en)
*
|
2000-04-27 |
2006-03-28 |
Macromed, Inc. |
Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
|
US6875441B2
(en)
*
|
2000-06-26 |
2005-04-05 |
Rxkinetix, Inc. |
Composition for delivery of hematopoietic growth factor
|
US20040185101A1
(en)
*
|
2001-03-27 |
2004-09-23 |
Macromed, Incorporated. |
Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
|
EP1446099B1
(de)
*
|
2001-11-14 |
2009-07-15 |
Durect Corporation |
Injizierbare depotzusammensetzungen
|
KR20040058101A
(ko)
|
2001-11-14 |
2004-07-03 |
알자 코포레이션 |
카테터 주입가능한 데포 조성물 및 그의 용도
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
DE60226282T2
(de)
|
2002-07-31 |
2009-09-17 |
Alza Corp., Mountain View |
Injizierbare depotzusammensetzungen und deren verwendung
|
WO2004011054A2
(en)
|
2002-07-31 |
2004-02-05 |
Alza Corporation |
Injectable multimodal polymer depot compositions and uses thereof
|
CN100408091C
(zh)
*
|
2003-01-14 |
2008-08-06 |
北京迈德康医药技术有限公司 |
重组人粒细胞巨噬细胞集落刺激因子凝胶剂及其制备方法
|
CN1446833A
(zh)
*
|
2003-02-08 |
2003-10-08 |
复旦大学 |
一种温敏性可降解微凝胶及其制备方法
|
US7051654B2
(en)
*
|
2003-05-30 |
2006-05-30 |
Clemson University |
Ink-jet printing of viable cells
|
GB2408510B
(en)
*
|
2003-11-28 |
2008-05-14 |
Ind Tech Res Inst |
Thermosensitive biodegradable copolymer
|
JP2007517042A
(ja)
*
|
2003-12-30 |
2007-06-28 |
デュレクト コーポレーション |
活性物質、好ましくはgnrhの制御放出のための、好ましくはpegおよびplgの混合物を含有するポリマーインプラント
|
US8778880B2
(en)
|
2004-02-02 |
2014-07-15 |
Ambrx, Inc. |
Human growth hormone modified at position 35
|
US7151077B2
(en)
*
|
2004-03-29 |
2006-12-19 |
Halliburton Energy Services, Inc. |
Polymersome compositions and associated methods of use
|
CA2568952C
(en)
|
2004-06-18 |
2019-05-21 |
Ambrx, Inc. |
Novel antigen-binding polypeptides and their uses
|
ES2395732T3
(es)
*
|
2004-08-02 |
2013-02-14 |
Samyang Corporation |
Composición polimérica multi-bloque biodegradable susceptible de transición sol-gel
|
US20060034889A1
(en)
*
|
2004-08-16 |
2006-02-16 |
Macromed, Inc. |
Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
|
WO2006039400A2
(en)
|
2004-09-29 |
2006-04-13 |
Mount Sinai School Of Medicine Of New York University |
Fsh and fsh receptor modulator compositions and methods for inhibiting osteoclastic bone resorption and bone loss in osteoporosis
|
US7235592B2
(en)
*
|
2004-10-12 |
2007-06-26 |
Zimmer Gmbh |
PVA hydrogel
|
AU2005322019B2
(en)
|
2004-12-22 |
2010-08-26 |
Ambrx, Inc. |
Formulations of human growth hormone comprising a non-naturally encoded amino acid
|
SG161210A1
(en)
|
2004-12-22 |
2010-05-27 |
Ambrx Inc |
Methods for expression and purification of recombinant human growth hormone
|
ATE541934T1
(de)
|
2004-12-22 |
2012-02-15 |
Ambrx Inc |
Zusammensetzungen von aminoacyl-trna-synthetase und verwendungen davon
|
KR20070090023A
(ko)
|
2004-12-22 |
2007-09-04 |
암브룩스, 인코포레이티드 |
변형 인간 성장 호르몬
|
US20060142234A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
US8128952B2
(en)
*
|
2005-01-12 |
2012-03-06 |
Clemson University Research Foundation |
Ligand-mediated controlled drug delivery
|
AU2006216655B2
(en)
*
|
2005-02-23 |
2012-05-31 |
Zimmer Technology, Inc. |
Blend hydrogels and methods of making
|
JP5749881B2
(ja)
|
2005-04-22 |
2015-07-15 |
ユニヴェルシテ デ ジュネーブ |
ポリラクチド組成物およびその使用
|
US7608567B2
(en)
*
|
2005-05-12 |
2009-10-27 |
Halliburton Energy Services, Inc. |
Degradable surfactants and methods for use
|
US7662753B2
(en)
|
2005-05-12 |
2010-02-16 |
Halliburton Energy Services, Inc. |
Degradable surfactants and methods for use
|
US7677315B2
(en)
|
2005-05-12 |
2010-03-16 |
Halliburton Energy Services, Inc. |
Degradable surfactants and methods for use
|
EP1893229B1
(de)
|
2005-06-03 |
2011-10-19 |
Ambrx, Inc. |
Verbesserte humane interferon-moleküle und ihre verwendungen
|
US7571295B2
(en)
*
|
2005-08-04 |
2009-08-04 |
Intel Corporation |
Memory manager for heterogeneous memory control
|
WO2007059312A2
(en)
|
2005-11-16 |
2007-05-24 |
Ambrx, Inc. |
Methods and compositions comprising non-natural amino acids
|
EP1957124A2
(de)
*
|
2005-12-07 |
2008-08-20 |
Zimmer Inc. |
Verfahren zur bindung oder modifizierung von hydrogels mit strahlung
|
US20070141108A1
(en)
*
|
2005-12-20 |
2007-06-21 |
Zimmer, Inc. |
Fiber-reinforced water-swellable articles
|
EP1801135B1
(de)
*
|
2005-12-22 |
2010-09-29 |
Zimmer Inc. |
Perfluorcyclobutanvernetzte Hydrogele
|
US9012605B2
(en)
|
2006-01-23 |
2015-04-21 |
Amgen Inc. |
Crystalline polypeptides
|
US8110242B2
(en)
*
|
2006-03-24 |
2012-02-07 |
Zimmer, Inc. |
Methods of preparing hydrogel coatings
|
KR20090051227A
(ko)
|
2006-09-08 |
2009-05-21 |
암브룩스, 인코포레이티드 |
척추동물 세포를 위한 하이브리드 서프레서 tRNA
|
AU2007292893B2
(en)
|
2006-09-08 |
2012-03-01 |
Ambrx, Inc. |
Suppressor tRNA transcription in vertebrate cells
|
JP5840345B2
(ja)
*
|
2006-09-08 |
2016-01-06 |
アンブルックス, インコーポレイテッドAmbrx, Inc. |
修飾ヒト血漿ポリペプチドまたは修飾ヒトFc足場タンパク質ならびにこれらの利用
|
EP1935434A1
(de)
*
|
2006-12-19 |
2008-06-25 |
Novosom AG |
Konstruktion und Verwendung von transfektionsverstärkenden Elementen
|
US8012931B2
(en)
|
2007-03-30 |
2011-09-06 |
Ambrx, Inc. |
Modified FGF-21 polypeptides and their uses
|
CA2685596A1
(en)
|
2007-05-02 |
2008-11-13 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
KR100838809B1
(ko)
*
|
2007-05-03 |
2008-06-17 |
성균관대학교산학협력단 |
겔강도가 우수한 온도 및 피에치 민감성 블록 공중합체 및이의 제조방법과 이를 이용한 약물전달체
|
US20080287633A1
(en)
*
|
2007-05-18 |
2008-11-20 |
Drumheller Paul D |
Hydrogel Materials
|
US7731988B2
(en)
*
|
2007-08-03 |
2010-06-08 |
Zimmer, Inc. |
Multi-polymer hydrogels
|
US20090043398A1
(en)
*
|
2007-08-09 |
2009-02-12 |
Zimmer, Inc. |
Method of producing gradient articles by centrifugation molding or casting
|
US8062739B2
(en)
*
|
2007-08-31 |
2011-11-22 |
Zimmer, Inc. |
Hydrogels with gradient
|
US20090104113A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Searete Llc |
Ionizing-radiation-responsive compositions, methods, and systems
|
US8164074B2
(en)
*
|
2007-10-18 |
2012-04-24 |
The Invention Science Fund I, Llc |
Ionizing-radiation-responsive compositions, methods, and systems
|
US8684898B2
(en)
*
|
2007-10-18 |
2014-04-01 |
The Invention Science Fund I Llc |
Ionizing-radiation-responsive compositions, methods, and systems
|
US8168958B2
(en)
*
|
2007-10-18 |
2012-05-01 |
The Invention Science Fund I, Llc |
Ionizing-radiation-responsive compositions, methods, and systems
|
US9557635B2
(en)
*
|
2007-10-18 |
2017-01-31 |
Gearbox, Llc |
Ionizing-radiation-responsive compositions, methods, and systems
|
US8227204B2
(en)
*
|
2007-10-18 |
2012-07-24 |
The Invention Science Fund I, Llc |
Ionizing-radiation-responsive compositions, methods, and systems
|
US8529426B2
(en)
*
|
2007-10-18 |
2013-09-10 |
The Invention Science Fund I Llc |
Ionizing-radiation-responsive compositions, methods, and systems
|
EP3257865A1
(de)
|
2007-11-16 |
2017-12-20 |
The Rockefeller University |
Für die protofibrillenform des proteins beta-amyloid spezifische antikörper
|
US7947784B2
(en)
*
|
2007-11-16 |
2011-05-24 |
Zimmer, Inc. |
Reactive compounding of hydrogels
|
JP5547083B2
(ja)
|
2007-11-20 |
2014-07-09 |
アンブルックス,インコーポレイテッド |
修飾されたインスリンポリペプチドおよびそれらの使用
|
US8034362B2
(en)
|
2008-01-04 |
2011-10-11 |
Zimmer, Inc. |
Chemical composition of hydrogels for use as articulating surfaces
|
US20090175840A1
(en)
*
|
2008-01-04 |
2009-07-09 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
US20090183503A1
(en)
*
|
2008-01-18 |
2009-07-23 |
Alberto Verdesi |
Exhaust apparatus
|
NZ620606A
(en)
|
2008-02-08 |
2015-08-28 |
Ambrx Inc |
Modified leptin polypeptides and their uses
|
US8858995B2
(en)
*
|
2008-03-10 |
2014-10-14 |
University Of Louisville Research Foundation, Inc. |
Methods and compositions for controlled delivery of phytochemical agents
|
TWI388591B
(zh)
*
|
2008-03-28 |
2013-03-11 |
Ind Tech Res Inst |
溫度敏感性材料
|
US8128983B2
(en)
*
|
2008-04-11 |
2012-03-06 |
Abbott Cardiovascular Systems Inc. |
Coating comprising poly(ethylene glycol)-poly(lactide-glycolide-caprolactone) interpenetrating network
|
CN102014957B
(zh)
*
|
2008-04-21 |
2014-12-10 |
奥德纳米有限公司 |
用于治疗耳部疾病和病况的耳用调配物
|
US8652506B2
(en)
*
|
2008-06-05 |
2014-02-18 |
Boston Scientific Scimed, Inc. |
Bio-degradable block co-polymers for controlled release
|
FR2932070B1
(fr)
|
2008-06-10 |
2012-08-17 |
Oreal |
Ensemble de maquillage et/ou de soin des cils
|
PE20110426A1
(es)
|
2008-07-23 |
2011-07-01 |
Ambrx Inc |
Polipeptidos g-csf bovinos modificados
|
KR101647164B1
(ko)
|
2008-09-26 |
2016-08-09 |
암브룩스, 인코포레이티드 |
변형된 동물 에리트로포이에틴 폴리펩티드 및 이의 용도
|
MX357314B
(es)
|
2008-09-26 |
2018-07-04 |
Ambrx Inc |
Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales.
|
TWI374903B
(en)
*
|
2008-12-31 |
2012-10-21 |
Ind Tech Res Inst |
Biodegradable copolymer hydrogel materials
|
FR2940761B1
(fr)
|
2009-01-07 |
2012-12-28 |
Polymerexpert Sa |
Composition anti-ronflement contenant un polymere thermogelifiant
|
WO2010146536A1
(en)
*
|
2009-06-18 |
2010-12-23 |
Koninklijke Philips Electronics N.V. |
Suspension of particles with drug
|
WO2011065916A1
(en)
|
2009-11-24 |
2011-06-03 |
Agency For Science, Technology And Research |
Crosslinking branched molecule through thiol-disulfide exchange to form hydrogel
|
SG181769A1
(en)
|
2009-12-21 |
2012-07-30 |
Ambrx Inc |
Modified porcine somatotropin polypeptides and their uses
|
CA2784793A1
(en)
|
2009-12-21 |
2011-07-21 |
Ambrx, Inc. |
Modified bovine somatotropin polypeptides and their uses
|
US9144598B2
(en)
|
2010-03-05 |
2015-09-29 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Reverse thermal gels and their use in cell therapy
|
US9132199B2
(en)
|
2010-03-05 |
2015-09-15 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Reverse thermal gels and uses therefor
|
US20110223156A1
(en)
*
|
2010-03-11 |
2011-09-15 |
Raibekas Andrei A |
Reversible gel protein formulation
|
EP2382966A1
(de)
*
|
2010-03-12 |
2011-11-02 |
DSM IP Assets B.V. |
Mizellenzusammensetzungen und Herstellungsverfahren dafür
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
EP2605789B1
(de)
|
2010-08-17 |
2019-06-05 |
Ambrx, Inc. |
Modifizierte relaxinpolypeptide und ihre verwendungen
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
SG193610A1
(en)
|
2011-03-25 |
2013-11-29 |
Amgen Inc |
Anti - sclerostin antibody crystals and formulations thereof
|
AU2012286817A1
(en)
|
2011-07-26 |
2014-02-13 |
The Curators Of The University Of Missouri |
Engineered comestible meat
|
TWI641396B
(zh)
|
2011-09-23 |
2018-11-21 |
Bvw控股公司 |
醫療共聚物
|
RU2625761C2
(ru)
*
|
2012-02-08 |
2017-07-18 |
Торэй Индастриз, Инк. |
Чувствительный к стимулам материал и медицинский материал, содержащий его
|
PL2859017T3
(pl)
|
2012-06-08 |
2019-07-31 |
Sutro Biopharma, Inc. |
Przeciwciała zawierające swoiste dla miejsca, niewystępujące naturalnie reszty aminokwasowe, sposoby ich wytwarzania i sposoby ich zastosowania
|
EP3135690A1
(de)
|
2012-06-26 |
2017-03-01 |
Sutro Biopharma, Inc. |
Modifizierte fc-proteine mit stellenspezifischen nichtnatürlichen aminosäureresten, konjugate daraus, verfahren zu deren herstellung und verfahren zu deren verwendung
|
CN104981254B
(zh)
|
2012-08-31 |
2018-05-22 |
苏特罗生物制药公司 |
含有叠氮基的经修饰的氨基酸
|
US10413496B2
(en)
|
2012-10-15 |
2019-09-17 |
L'oreal |
Aqueous wax dispersions
|
US10626294B2
(en)
|
2012-10-15 |
2020-04-21 |
L'oreal |
Aqueous wax dispersions containing volatile solvents
|
US9408785B2
(en)
|
2012-10-15 |
2016-08-09 |
L'oreal |
Hair styling compositions containing aqueous wax dispersions
|
EP2813242A1
(de)
*
|
2013-06-13 |
2014-12-17 |
PLS-Design GmbH |
Niedermolekulare Immunmodulatoren als Unterstützung für eine spezifische Immuntherapie
|
ES2865473T3
(es)
|
2013-07-10 |
2021-10-15 |
Sutro Biopharma Inc |
Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso
|
WO2015038988A1
(en)
|
2013-09-13 |
2015-03-19 |
Modern Meadow, Inc. |
Edible and animal-product-free microcarriers for engineered meat
|
EP3055298B1
(de)
|
2013-10-11 |
2020-04-29 |
Sutro Biopharma, Inc. |
Modifizierte aminosäuren mit funktionellen tetrazingruppen, verfahren zur herstellung und verfahren zu deren verwendung
|
EP3079668A1
(de)
|
2013-12-09 |
2016-10-19 |
Durect Corporation |
Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit
|
WO2015097236A2
(en)
*
|
2013-12-24 |
2015-07-02 |
Ares Trading S.A |
Fgf-18 formulation in alginate/collagen hydrogels
|
CN103751102A
(zh)
*
|
2014-01-15 |
2014-04-30 |
上海交通大学 |
一种胶原酶温敏水凝胶及其制备方法和应用
|
EP3101116A4
(de)
*
|
2014-01-29 |
2017-10-04 |
Daikin Industries, Ltd. |
Temperaturreaktives basismaterial, verfahren zur herstellung davon und verfahren zur beurteilung davon
|
EP3102043A4
(de)
|
2014-02-05 |
2017-08-09 |
Modern Meadow, Inc. |
Getrocknete lebensmittelprodukte aus kultivierten muskelzellen
|
US10561596B2
(en)
|
2014-04-11 |
2020-02-18 |
L'oreal |
Compositions and dispersions containing particles comprising a polymer
|
CA2954773C
(en)
|
2014-07-14 |
2023-10-03 |
Amgen Inc. |
Crystalline antibody formulations
|
US20170198059A1
(en)
|
2014-07-14 |
2017-07-13 |
Amgen Inc. |
Crystalline antibody formulations
|
CN114805532A
(zh)
|
2014-10-24 |
2022-07-29 |
百时美施贵宝公司 |
修饰的fgf-21多肽及其用途
|
EP3261582B1
(de)
*
|
2015-02-26 |
2021-01-06 |
Remodeless CV Ltd. |
Verfahren und zusammensetzungen in zusammenhang mit leptin-antagonisten
|
US11913166B2
(en)
|
2015-09-21 |
2024-02-27 |
Modern Meadow, Inc. |
Fiber reinforced tissue composites
|
RU2732502C2
(ru)
|
2016-02-10 |
2020-09-18 |
Ратгерс, Де Стейт Юниверсити Оф Нью Джерси |
Новые моноклональные антитела к LAM и PIM6/LAM для диагностики и лечения инфекций, вызванных Mycobacterium tuberculosis
|
BR112017016266A2
(pt)
|
2016-02-15 |
2018-03-27 |
Modern Meadow, Inc. |
método para produzir um material biofabricado.
|
WO2018044970A1
(en)
|
2016-08-31 |
2018-03-08 |
University Of Rochester |
Human monoclonal antibodies to human endogenous retrovirus k envelope (herv-k) and uses thereof
|
AU2018219283B2
(en)
|
2017-02-08 |
2022-05-19 |
Bristol-Myers Squibb Company |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
|
CN110832006B
(zh)
*
|
2017-04-28 |
2022-10-14 |
赢创运营有限公司 |
可生物降解的骨胶
|
AU2018253595A1
(en)
|
2017-11-13 |
2019-05-30 |
Modern Meadow, Inc. |
Biofabricated leather articles having zonal properties
|
FI3849614T3
(fi)
|
2018-09-11 |
2024-02-08 |
Ambrx Inc |
Interleukiini-2-polypeptidikonjugaatteja ja niiden käyttöjä
|
US20220009986A1
(en)
|
2018-10-19 |
2022-01-13 |
Ambrx, Inc. |
Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
|
EP3704202A4
(de)
|
2019-01-17 |
2020-12-16 |
Modern Meadow, Inc. |
Geschichtete kollagenmaterialien und verfahren zu ihrer herstellung
|
FR3091996B1
(fr)
|
2019-01-24 |
2021-01-29 |
Les Laboratoires Brothier |
Composition cicatrisante
|
KR20210136014A
(ko)
|
2019-02-12 |
2021-11-16 |
암브룩스, 인코포레이티드 |
항체-tlr 작용제 콘쥬게이트를 함유하는 조성물, 방법 및 이의 용도
|
KR20220140711A
(ko)
|
2020-01-13 |
2022-10-18 |
듀렉트 코퍼레이션 |
불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
|
AU2021233909A1
(en)
|
2020-03-11 |
2022-09-29 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and methods of use thereof
|
CA3190606A1
(en)
|
2020-08-20 |
2022-02-24 |
Ambrx, Inc. |
Antibody-tlr agonist conjugates, methods and uses thereof
|
KR20240004342A
(ko)
|
2021-04-03 |
2024-01-11 |
암브룩스, 인코포레이티드 |
항-her2 항체-약물 접합체 및 이의 용도
|